Skip Navigation

  • PRINT  | 

Media Advisory: Advisory Committee on Blood Safety and Availability Meeting

For Immediate Release:
April 24, 1997


The Advisory Committee on Blood Safety and Availability of the U.S. Department of Health and Human Services will hold its first meeting on Thursday and Friday, April 24 and 25, 1997. The principal subject of discussion will be Hepatitis C and Blood Transfusion and whether the Committee should recommend a Hepatitis C "lookback" to identify people who previously received blood from donors who now test positive for Hepatitis C.


Presenters will be:

Paul Mied, Ph.D.
Deputy Director, Division of Transfusion Transmitted Diseases
Food and Drug Administration
FDA Policies on "Lookback"

Jay Hoofnagle, M.D.
Director for Digestive Diseases, Division of Digestive Diseases and Nutrition National Institute of Diabetes and Digestive and Kidney Diseases
Clinical Aspects and Treatment

Harold Margolis, M.D.
Chief, Hepatitis Branch, Centers for Disease Control and Prevention
Scientific Background and Public Health Service Recommendations

Merlyn Sayers, M.D.
President and Chief Executive Officer, BloodCare, Dallas, TX
Blood Center Issues Concerning Hepatitis C "Lookback"


The meeting will begin at 8:30 a.m. on Thursday, and the Hepatitis C discussion is scheduled to begin at 11:20 a.m. that morning. The Committee is scheduled to vote on its recommendations on Friday morning, at 10:00 a.m.


Masur Auditorium, NIH Clinical Center, 10 Center Drive, National Institutes of Health